Literature DB >> 15569803

Age-wise exposure rates to hepatitis e virus in a southern Indian patient population without liver disease.

Hubert Darius J Daniel1, Aswin Warier, Priya Abraham, Gopalan Sridharan.   

Abstract

To determine the age-stratified exposure to hepatitis E virus (HEV) in patients attending a tertiary care hospital in southern India, serum samples from 600 individuals were tested using a commercial HEV IgG enzyme-linked immunosorbent assay. Subjects were composed of blood donors, antenatal women, and pre-operative individuals who were negative for hepatitis B surface antigen and antibody to hepatitis C virus with no evidence of liver disease; 200 each were 1-5 and 6-15 years old and 100 each were 16-40 and > or = 41 years old. One (0.5%) sample was positive in those 1-5 years old, two (1.0%) in those 6-15 years old, eight (8%) in those 16-40 years old, and 13 (13%) in those > or = 41 years old. The overall seropositivity rate was 4%. However, there was an age-related increase in exposure to HEV that was statistically significant (P < 0.001), with a higher HEV seropositivity in urban individuals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15569803

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  8 in total

1.  Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses.

Authors:  Nereida Jiménez de Oya; Estela Escribano-Romero; Ana-Belén Blázquez; María Lorenzo; Miguel A Martín-Acebes; Rafael Blasco; Juan-Carlos Saiz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  Jaundice in a traveler returning from India.

Authors:  Aaron Woofter; Norman Sussman
Journal:  MedGenMed       Date:  2006-02-16

3.  A study of Hepatitis A and E virus seropositivity profile amongst young healthy adults in India.

Authors:  Atul Kotwal; Harpreet Singh; A K Verma; R M Gupta; Shishir Jain; S Sinha; R K Joshi; Prabhakar Teli; Vijay Khunga; Anuj Bhatnagar; Richa Ranjan
Journal:  Med J Armed Forces India       Date:  2014-07-16

4.  Detection of hepatitis E virus-specific immunoglobulin a in patients infected with hepatitis E virus genotype 1 or 3.

Authors:  M Herremans; E Duizer; E Jusic; M P G Koopmans
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

5.  Serological immunoassay for detection of hepatitis E virus on the basis of genotype 3 open reading frame 2 recombinant proteins produced in Trichoplusia ni larvae.

Authors:  Nereida Jiménez de Oya; Inmaculada Galindo; Olivia Gironés; Erwin Duizer; José M Escribano; Juan-Carlos Saiz
Journal:  J Clin Microbiol       Date:  2009-08-05       Impact factor: 5.948

6.  Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity.

Authors:  M Herremans; J Bakker; E Duizer; H Vennema; M P G Koopmans
Journal:  Clin Vaccine Immunol       Date:  2007-03-14

7.  Development of a novel enzyme-linked immunosorbent assay to detect anti-IgG against swine hepatitis E virus.

Authors:  Won Jung Lee; Min Kyoung Shin; Seung Bin Cha; Han Sang Yoo
Journal:  J Vet Sci       Date:  2013-12-19       Impact factor: 1.672

8.  Setting a Course for Preventing Hepatitis E in Low and Lower-Middle-Income Countries: A Systematic Review of Burden and Risk Factors.

Authors:  Aybüke Koyuncu; Daniel Mapemba; Iza Ciglenecki; Emily S Gurley; Andrew S Azman
Journal:  Open Forum Infect Dis       Date:  2021-04-13       Impact factor: 3.835

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.